Suppr超能文献

感染性心内膜炎的抗生素预防:一项系统评价和荟萃分析。

Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis.

作者信息

Cahill Thomas J, Harrison James L, Jewell Paul, Onakpoya Igho, Chambers John B, Dayer Mark, Lockhart Peter, Roberts Nia, Shanson David, Thornhill Martin, Heneghan Carl J, Prendergast Bernard D

机构信息

Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK.

Department of Cardiology, St Thomas Hospital, London, UK.

出版信息

Heart. 2017 Jun;103(12):937-944. doi: 10.1136/heartjnl-2015-309102. Epub 2017 Feb 17.

Abstract

OBJECTIVE

The use of antibiotic prophylaxis (AP) for prevention of infective endocarditis (IE) is controversial. In recent years, guidelines to cardiologists and dentists have advised restriction of AP to high-risk groups (in Europe and the USA) or against its use at all (in the UK). The objective of this systematic review was to appraise the evidence for use of AP for prevention of bacteraemia or IE in patients undergoing dental procedures.

METHODS

We conducted electronic searches in Medline, Embase, Cochrane Library and ISI Web of Science. We assessed the methodological characteristics of included studies using the Strengthening the Reporting of Observational Studies in Epidemiology criteria for observational studies and the Cochrane Risk of Bias Tool for trials. Two reviewers independently determined the eligibility of studies, assessed the methodology of included studies and extracted the data.

RESULTS

We identified 178 eligible studies, of which 36 were included in the review. This included 10 time-trend studies, 5 observational studies and 21 trials. All trials identified used bacteraemia as an endpoint rather than IE. One time-trend study suggests that total AP restriction may be associated with a rising incidence of IE, while data on the consequences of relative AP restriction are conflicting. Meta-analysis of trials indicates that AP is effective in reducing the incidence of bacteraemia (risk ratio 0.53, 95% CI 0.49 to 0.57, p<0.01), but case-control studies suggest this may not translate to a statistically significant protective effect against IE in patients at low risk of disease.

CONCLUSIONS

The evidence base for the use of AP is limited, heterogeneous and the methodological quality of many studies is poor. Postprocedural bacteraemia is not a good surrogate endpoint for IE. Given the logistical challenges of a randomised trial, high-quality case-control studies would help to evaluate the role of dental procedures in causing IE and the efficacy of AP in its prevention.

摘要

目的

使用抗生素预防(AP)来预防感染性心内膜炎(IE)存在争议。近年来,针对心脏病专家和牙医的指南建议将AP的使用限制在高危人群(在欧洲和美国),或完全反对使用(在英国)。本系统评价的目的是评估在接受牙科手术的患者中使用AP预防菌血症或IE的证据。

方法

我们在Medline、Embase、Cochrane图书馆和ISI科学网进行了电子检索。我们使用流行病学观察性研究报告强化标准评估纳入研究的方法学特征,对于试验则使用Cochrane偏倚风险工具。两名 reviewers 独立确定研究的 eligibility,评估纳入研究的方法并提取数据。

结果

我们识别出178项 eligible 研究,其中36项纳入本评价。这包括10项时间趋势研究、5项观察性研究和21项试验。所有识别出的试验均将菌血症作为终点而非IE。一项时间趋势研究表明,完全限制AP可能与IE发病率上升有关,而关于相对限制AP的后果的数据相互矛盾。试验的荟萃分析表明,AP可有效降低菌血症的发病率(风险比0.53,95%CI 0.49至0.57,p<0.01),但病例对照研究表明,这可能不会转化为对低疾病风险患者预防IE的统计学显著保护作用。

结论

使用AP的证据基础有限、异质性大,且许多研究的方法学质量较差。术后菌血症不是IE的良好替代终点。鉴于随机试验的后勤挑战,高质量的病例对照研究将有助于评估牙科手术在导致IE中的作用以及AP在预防IE中的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验